As an alternative to statins, Sytrinol®LNA leverages the synergy of leucine and nicotinic acid with polymethoxylated flavones and tocotrienols to manage lipid biomarkers, fat oxidation, and circadian rhythms.
The axis between SIRT1/NAD+/AMPK is the focus of Sytrinol® LNA and its ability to manage metabolism and dyslipidemia.
The axis between SIRT1/NAD+/AMPK is the focus of Sytrinol® LNA and its ability to manage metabolism and dyslipidemia.